New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus

Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:An Bras Dermatol
Autori principali: Pasin, Victor Pavan, Pereira, Amanda Regio, de Carvalho, Kalline Andrade, de Paiva, João Marcos Góes, Enokihara, Milvia Maria Simões e Silva, Porro, Adriana Maria
Natura: Artigo
Lingua:Inglês
Pubblicazione: Sociedade Brasileira de Dermatologia 2015
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540539/
https://ncbi.nlm.nih.gov/pubmed/26312705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20153672
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi